$71.78
Today
as of Jul 22, 16:55 ET
Last 30 days
Recent Press Releases & News
Q1 Earnings Outperformers: Bio-Techne (NASDAQ:TECH) And The Rest Of The Research Tools & Consumables Stocks
The $11 Billion Reason TECH Stock Is Up Today
Bio-Techne (TECH) Agrees To $11.5 Billion Merck KGaA Buyout
Overview
52-week range
$43
$72
99% of range
Avg surprise (last 3)
+7.3%
Avg reaction (last 2)
-7.1%
50% positive
Latest IV / EM
26%
EM ±6.1% · $70 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 6, 2026 | Mar/2026 | $0.48 | $0.48 | 0.0% | -4.0% | -16.4% | earnings |
| Wed Dec 31, 2025 | Dec 2025 | $0.24 | — | — | — | — | financials |
| Tue Sep 30, 2025 | Sep 2025 | $0.24 | — | — | — | — | financials |
| Wed Aug 6, 2025 | Jun/2025 | $0.51 | $0.46 | +10.9% | — | — | earnings |
| Wed May 7, 2025 | Mar/2025 | $0.50 | $0.45 | +11.1% | — | +2.2% | earnings |
| Tue Dec 31, 2024 | Dec 2024 | $0.22 | — | — | — | — | financials |
| Mon Sep 30, 2024 | Sep 2024 | $0.21 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.31 | — | — | — | — | financials |
| Sun Dec 31, 2023 | Dec 2023 | $0.17 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.31 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Wed Aug 5, 2026 | Jun/2026 | OTHER | $0.46 | $0.51 | -9.8% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $311M | $296M | $287M | — | $316M | $297M | $289M | — |
| Cost of revenue | $103M | $105M | $98M | — | $102M | $103M | $106M | — |
| Gross profit | $208M | $191M | $188M | — | $215M | $194M | $183M | — |
| Operating income | $75M | $54M | $48M | — | $39M | $47M | $40M | — |
| Net income | $51M | $38M | $38M | — | $23M | $35M | $34M | — |
| EPS (diluted) | $0.32 | $0.24 | $0.24 | — | $0.14 | $0.22 | $0.21 | — |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $210M | $173M | $145M | $162M | $141M | $178M | $188M | $152M |
| Inventory | $201M | $205M | $203M | $189M | $191M | $188M | $185M | $180M |
| Total current assets | $688M | $637M | $610M | $608M | $627M | $635M | $649M | $617M |
| Total assets | $2.55B | $2.52B | $2.53B | $2.56B | $2.64B | $2.67B | $2.74B | $2.70B |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | — | — | — | — | — | — | — | — |
| Total equity | $2.09B | $2.01B | — | $1.92B | $2.02B | $2.08B | $2.14B | $2.07B |